Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of JP-1366 Oral Administration in Healthy Male Subjects
Clinical trial NCT03383042 · COMPLETED
Trial details
- NCT number
- NCT03383042
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-22
- Primary completion
- 2018-11-23
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.